未知生产厂商
IRX-2 contains a human leukocyte-derived cytokine mixture. It is being investigated to promote or enhance an anti-cancer immune response.
IRX-2 contains a human leukocyte-derived cytokine mixture. It is being investigated to promote or enhance an anti-cancer immune response.
Investigated for use/treatment in cancer/tumors (unspecified), head and neck cancer, and solid tumors.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
